MetaCap

Electra Therapeutics Inc. (ETRA)

NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.11-0.83 (-9.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ETRA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$509.85M
EPS (TTM)
-$35.94
52-week range
6.87 – 15.50
Day range
8.07 – 9.65
Volume / Avg
376.12K / 559.28K
Beta
—

52-week range

$6.87$15.50

ETRA stock today

Electra Therapeutics (ETRA) closed at $8.11 on Nov 20, down 9.28% (-$0.83), versus the S&P 500's 3.70% decline. At this level, ETRA sits near the bottom of its 52-week range of $6.87 to $15.50: 47.7% below the high, set on Sep 18, 2026 and 18.0% above the low. Electra Therapeutics has posted a net loss over the last twelve months (EPS of -$35.94), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Electra Therapeutics

Company profile

Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Quehuong Dong M.B.A., Pharm.D.
Headquarters
South San Francisco, CA
Employees
46
IPO year
2026

Analyst forecast

Forecast

Consensus (6 analysts)

strong_buy

Avg. price target

$33.20+309.37%

  • Strong buy 1
  • Buy 5
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $30.00High $36.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-3.47 vs $-1.76
Surprise
-97.16%

ETRA news

All ETRA news

Electra Therapeutics peers

Health Care sector
ETRA peer companies
CompanyPrice% ChgMarket capCompare
VALNValneva SE ADR5.16-3.82%$490.86Mvs ETRA
DNAGinkgo Bioworks Holdings Inc. Class A7.46-9.02%$483.54Mvs ETRA
SANASana Biotechnology Inc.1.59-8.62%$476.42Mvs ETRA
RGNXREGENXBIO Inc.7.16-0.28%$473.44Mvs ETRA
FENCFennec Pharmaceuticals Inc.13.09-2.68%$462.14Mvs ETRA
DBVTDBV Technologies S.A. ADR9.02-4.25%$566.82Mvs ETRA
ENTXEntera Bio Ltd.3.31+0.76%$575.53Mvs ETRA
FDMT4D Molecular Therapeutics Inc.10.23-4.57%$576.76Mvs ETRA

Indexes, lists and sector

Electra Therapeutics stock FAQ

What is Electra Therapeutics's stock price today?

ETRA last traded at $8.11 as of Nov 20, 4:00 PM EST, down 9.28% on the day. Prices are delayed at least 15 minutes.

Who is Electra Therapeutics's CEO?

Dr. Quehuong Dong M.B.A., Pharm.D. is the chief executive officer of Electra Therapeutics Inc., which has about 46 employees.

What is the ETRA 52-week high?

The 52-week high for ETRA is $15.50 and the 52-week low is $6.87. The stock is currently 47.7% below its high.

Compare ETRA